Global API Contract Manufacturing Market Growth (Status and Outlook) 2019-2024
Table of Contents
2019-2024 Global API Contract Manufacturing Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global API Contract Manufacturing Market Size 2014-2024
- 2.1.2 API Contract Manufacturing Market Size CAGR by Region
- 2.2 API Contract Manufacturing Segment by Type
- 2.2.1 Commercial Manufacturing
- 2.2.2 Clinical Manufacturing
- 2.3 API Contract Manufacturing Market Size by Type
- 2.3.1 Global API Contract Manufacturing Market Size Market Share by Type (2014-2019)
- 2.3.2 Global API Contract Manufacturing Market Size Growth Rate by Type (2014-2019)
- 2.4 API Contract Manufacturing Segment by Application
- 2.4.1 Oncology
- 2.4.2 Central nervous system
- 2.4.3 Cardiovascular disorder
- 2.4.4 Infectious diseases
- 2.4.5 Pulmonary disorders
- 2.4.6 Metabolic disorder
- 2.4.7 Gastrointestinal disorders
- 2.4.8 Musculoskeletal disorders
- 2.4.9 Genitourinary disorders
- 2.4.10 Endocrinology
- 2.5 API Contract Manufacturing Market Size by Application
- 2.5.1 Global API Contract Manufacturing Market Size Market Share by Application (2014-2019)
- 2.5.2 Global API Contract Manufacturing Market Size Growth Rate by Application (2014-2019)
3 Global API Contract Manufacturing by Players
- 3.1 Global API Contract Manufacturing Market Size Market Share by Players
- 3.1.1 Global API Contract Manufacturing Market Size by Players (2017-2019)
- 3.1.2 Global API Contract Manufacturing Market Size Market Share by Players (2017-2019)
- 3.2 Global API Contract Manufacturing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 API Contract Manufacturing by Regions
- 4.1 API Contract Manufacturing Market Size by Regions
- 4.2 Americas API Contract Manufacturing Market Size Growth
- 4.3 APAC API Contract Manufacturing Market Size Growth
- 4.4 Europe API Contract Manufacturing Market Size Growth
- 4.5 Middle East & Africa API Contract Manufacturing Market Size Growth
5 Americas
- 5.1 Americas API Contract Manufacturing Market Size by Countries
- 5.2 Americas API Contract Manufacturing Market Size by Type
- 5.3 Americas API Contract Manufacturing Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC API Contract Manufacturing Market Size by Countries
- 6.2 APAC API Contract Manufacturing Market Size by Type
- 6.3 APAC API Contract Manufacturing Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe API Contract Manufacturing by Countries
- 7.2 Europe API Contract Manufacturing Market Size by Type
- 7.3 Europe API Contract Manufacturing Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa API Contract Manufacturing by Countries
- 8.2 Middle East & Africa API Contract Manufacturing Market Size by Type
- 8.3 Middle East & Africa API Contract Manufacturing Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global API Contract Manufacturing Market Forecast
- 10.1 Global API Contract Manufacturing Market Size Forecast (2019-2024)
- 10.2 Global API Contract Manufacturing Forecast by Regions
- 10.2.1 Global API Contract Manufacturing Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global API Contract Manufacturing Forecast by Type
- 10.8 Global API Contract Manufacturing Forecast by Application
11 Key Players Analysis
- 11.1 AstraZeneca Plc
- 11.1.1 Company Details
- 11.1.2 API Contract Manufacturing Product Offered
- 11.1.3 AstraZeneca Plc API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 AstraZeneca Plc News
- 11.2 BoehringerIngelhein GmbH
- 11.2.1 Company Details
- 11.2.2 API Contract Manufacturing Product Offered
- 11.2.3 BoehringerIngelhein GmbH API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 BoehringerIngelhein GmbH News
- 11.3 GlaxoSmithKline Pharmaceuticals Ltd
- 11.3.1 Company Details
- 11.3.2 API Contract Manufacturing Product Offered
- 11.3.3 GlaxoSmithKline Pharmaceuticals Ltd API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 GlaxoSmithKline Pharmaceuticals Ltd News
- 11.4 Merck&Co.,Inc
- 11.4.1 Company Details
- 11.4.2 API Contract Manufacturing Product Offered
- 11.4.3 Merck&Co.,Inc API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Merck&Co.,Inc News
- 11.5 Novartis AG
- 11.5.1 Company Details
- 11.5.2 API Contract Manufacturing Product Offered
- 11.5.3 Novartis AG API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Novartis AG News
- 11.6 Piramal Pharma Solutions
- 11.6.1 Company Details
- 11.6.2 API Contract Manufacturing Product Offered
- 11.6.3 Piramal Pharma Solutions API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Piramal Pharma Solutions News
- 11.7 Ranbaxy Laboratories Ltd.
- 11.7.1 Company Details
- 11.7.2 API Contract Manufacturing Product Offered
- 11.7.3 Ranbaxy Laboratories Ltd. API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Ranbaxy Laboratories Ltd. News
- 11.8 Reddy's Laboratories Ltd
- 11.8.1 Company Details
- 11.8.2 API Contract Manufacturing Product Offered
- 11.8.3 Reddy's Laboratories Ltd API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Reddy's Laboratories Ltd News
- 11.9 Sandoz-Lek-Biochemie
- 11.9.1 Company Details
- 11.9.2 API Contract Manufacturing Product Offered
- 11.9.3 Sandoz-Lek-Biochemie API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Sandoz-Lek-Biochemie News
- 11.10 Sun Pharmaceutical Industries Ltd
- 11.10.1 Company Details
- 11.10.2 API Contract Manufacturing Product Offered
- 11.10.3 Sun Pharmaceutical Industries Ltd API Contract Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Sun Pharmaceutical Industries Ltd News
- 11.11 Teva Pharmaceuticals Industries Ltd
12 Research Findings and Conclusion
Contract manufacturing is the process where manufacturer engages into an agreement with the companies for component or product manufacturing. Active pharmaceutical ingredient (API) contract manufacturing refers to the development of pharmaceutical drugs through contract manufacturing by outsourcing to other companies.
According to this study, over the next five years the API Contract Manufacturing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in API Contract Manufacturing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of API Contract Manufacturing market by product type, application, key companies and key regions.
This study considers the API Contract Manufacturing value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Commercial Manufacturing
Clinical Manufacturing
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Oncology
Central nervous system
Cardiovascular disorder
Infectious diseases
Pulmonary disorders
Metabolic disorder
Gastrointestinal disorders
Musculoskeletal disorders
Genitourinary disorders
Endocrinology
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca Plc
BoehringerIngelhein GmbH
GlaxoSmithKline Pharmaceuticals Ltd
Merck&Co.,Inc
Novartis AG
Piramal Pharma Solutions
Ranbaxy Laboratories Ltd.
Reddy's Laboratories Ltd
Sandoz-Lek-Biochemie
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals Industries Ltd
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global API Contract Manufacturing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of API Contract Manufacturing market by identifying its various subsegments.
Focuses on the key global API Contract Manufacturing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the API Contract Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of API Contract Manufacturing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.